Atossa Therapeutics
ATOS
#9430
Rank
HK$0.64 B
Marketcap
HK$5.03
Share price
-1.21%
Change (1 day)
-28.27%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -HK$0.24 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$0.2 Billion, an increase over its 2023 earnings that were of -HK$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.24 Billion18.4%
2024 -HK$0.2 Billion-15.25%
2023 -HK$0.24 Billion11.62%
2022 -HK$0.22 Billion30.84%
2021 -HK$0.17 Billion15.58%
2020 -HK$0.14 Billion3.41%
2019 -HK$0.14 Billion51.16%
2018 -HK$88.87 Million40.41%
2017 -HK$63.3 Million27.54%
2016 -HK$49.63 Million-47.49%
2015 -HK$94.51 Million-17.25%
2014 -HK$0.12 Billion35.91%
2013 -HK$84.04 Million112.3%
2012 -HK$39.59 Million46.53%
2011 -HK$27.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$252.42 B-107,442.61%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$10.38 B-4,517.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$10.02 B-4,364.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$61.1 Million-74.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
HK$0.32 B-238.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$0.86 Billion 261.87%๐Ÿ‡บ๐Ÿ‡ธ USA